Interventional Management of Stroke (IMS) II Study
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effects of delivering intra-arterial recombinant
tissue plasminogen activator (rt-PA) and ultrasound to the site of the blood clot blocking
blood flow to the brain of stroke patients.
Phase:
Phase 2
Details
Lead Sponsor:
University of Cincinnati
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)